Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 116,672 shares at $13.14 ($1.5M) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($1.5M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.14 | 58,336 | $767K | 50.0% |
| 2 | $13.14 | 58,336 | $767K | 50.0% |
| Total | $13.14 avg | 116,672 | $1.5M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |
| VRNA | SELL | 2024-11-26 | $1.2M | — | Filing → |